(c) Medically appropriate for telehealth
means that an in-person physical examination of the claimant is not needed in
order to assess the claimant's clinical status, need for further diagnostic
testing, appropriate treatment, or the determination of causal relationship or
level of disability. The terms and factors referenced in this subdivision use
medical terms of art in the context of best medical practice and are parameters
by which providers should prospectively determine whether an in-person physical
examination is necessary and should not be the basis of a denial by carriers,
self-insured employers, or third-party administrators.
(1) Factors where an in-person physical
examination may not be necessary and therefore treatment by telehealth may be
medically appropriate include but are not limited to:
(i) Management of chronic conditions where
the Authorized Medical Provider has previously conducted a medically
appropriate and comprehensive in-person assessment of the patient and condition
and is fully familiar with the applicable medical history.
(ii) Discussion of test results.
(iii) Counseling about diagnostic and
therapeutic options.
(iv)
Dermatology, for visits not requiring palpation or biopsy of a lesion to
accurately diagnose or treat the condition.
(v) Prescriptions for medication, subject to
the limitations in paragraph (2) of this subdivision.
(vi) Nutrition counseling.
(vii) Mental health counseling, for which
in-person assessment of body movements, postures, and other nonverbal cues is
not needed for accurate diagnosis, treatment, or interim assessment of a
condition or the potential adverse side-effects of a medication.
(viii) Other clinical scenarios as may be
prescribed in Medical Treatment Guidelines or other related Board
communications.
(2)
Factors that indicate an in-person physical examination is necessary and
treatment via telehealth is not medically appropriate include but are not
limited to:
(i) Health concerns that require
a procedure.
(ii) Abdominal pain,
chest pain, clinically altered mental status, any situation in which it appears
the claimant may pose a risk to themselves or others, severe headache, signs or
symptoms of a stroke, or any other clinical presentation that is generally
accepted as requiring in-person, emergent or urgent medical assessment, and for
which in-person resources (e.g. regional hospital emergency departments or
free-standing urgent care centers, as may be clinically appropriate) are
readily available.
(iii) Eye or
vision complaints.
(iv) Highly
nuanced or multiple complex health concerns requiring an in-person examination
to assess subtle interactions between co-morbidities or medications.
(v) Any situation in which an in-person
physical exam might reasonably impact the accuracy, quality, or certainty of
the Authorized Medical Provider's assessment, treatment, or
recommendations.
(vi) Any situation
where an in-person physical examination is needed to assess disability or range
of motion, including but not limited to strength testing, formal range of
motion testing, assessment of joint stability, nuanced orthopedic and/or
neurologic testing, spirometry or pulmonary function testing, or exercise
tolerance testing.
(vii) Any
physical therapy, occupational therapy, or chiropractic services utilizing
physical modalities other than instruction on range of motion or strengthening
exercises.
(viii) Any other
clinical scenarios as may be prescribed in Medical Treatment Guidelines or
other related Board communications.
(ix) Assessment of causal relationship for an
injury or illness unless an in-person physical examination is not necessary to
make the determination of causal relationship, in which case the Authorized
Medical Provider must specifically articulate in the medical record why an
in-person examination was not necessary in order to make a determination of
causal relationship.
(3)
Notwithstanding any of the factors listed in paragraph (1) of this subdivision,
the following procedures or situations are not medically appropriate for
telehealth:
(ii) The initial prescription of long-term
medications or follow-up monitoring of those medications without periodic
in-person evaluation.
(iii) Where
the nature of treatment set forth in the Medical Treatment Guidelines
necessitates an in-person examination.
(iv) Assessment of permanent
disability.
(v) Any other clinical
scenarios as may be outlined by the Board in Medical Treatment Guidelines or
other related Board communications.
(vi) The patient lacks suitable technology or
equipment necessary to conduct the telehealth visit.
(vii) The patient has physical and/or
cognitive challenges that would be a barrier to an effective telehealth visit
(without the assistance of another individual).
(viii) The patient has expressed a preference
for an in-person visit, as well as a willingness and capability to travel to an
in-person visit.